Ntla.org

Ntla.org has Server used 35.174.132.21 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first Unknown and hosted in Ann Arbor United States, server ping response time 12 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Ntla keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Ntla stock
2 Ntla
3 Ntla stock price
4 Ntlai
5 Ntlab
6 Ntlame
7 Ntlan
8 Ntlapa
9 Ntlapd

Hosting Provider

Website: Ntla.org
Hostname: ec2-35-174-132-21.compute-1.amazonaws.com
Country:
NetName:
Address: 410 Terry Ave N.,
Region: MI
City: Ann Arbor
Postal Code: 48104
Latitude: 42.273399353027
Longitude: -83.713302612305
Area Code: 734
Email Abuse1. [email protected]
2. [email protected]
3. [email protected]
4. [email protected]

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (4 hours ago)

   » Bobbyjonesband.com (2 day ago)

   » Huishoubao.com (3 hours ago)

   » M1file.com (3 day ago)

   » Renhomesantalya.com (10 day ago)

   » Napadrivertours.com (4 day ago)

Results For Websites Listing

Found 48 Websites with content related to this domain, It is result after search with search engine

National Tax Lien Association

Ntla.org   DA: 12 PA: 12 MOZ Rank: 24

  • The National Tax Lien Association (NTLA) is the only national non-profit trade association dedicated to America's tax sale industry
  • As the industry's centralized voice, we promote the benefits of tax lien and tax deed sales as reliable income for municipal, county and state budgets
  • We provide unbiased, quality education and a path to the only

Intellia Therapeutics, Inc. (NTLA) Stock Price, News

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 29

NTLA-5001 is an autologous T cell receptor (TCR)-T cell therapy engineered to target the Wilms' Tumor (WT1) antigen for the treatment of all genetic subtypes of acute myeloid leukemia (AML).

NTLA Intellia Therapeutics — Stock Price And Discussion

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 28

  • NTLA Intellia Therapeutics — Stock Price and Discussion | Stocktwits
  • Intellia Therapeutics NASDAQ Updated Aug 27, 2021 11:56 PM
  • NTLA 160.00 5.52 (3.57%) Post-Market 0.99 (0.62%) 9,473

NTLA Stock Price Intellia Therapeutics Inc. Stock Quote

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 43

  • NTLA | Complete Intellia Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

NTLA – National Tribal Land Association

Ntla.info   DA: 13 PA: 13 MOZ Rank: 30

  • NTLA is committed to helping tribal land professionals enhance their skills and knowledge through professional development
  • All of the online courses in Level I, II and III of the Tribal Land Office Professionals Certification Program are now available.

Intellia Therapeutics, Inc. (NTLA) Options Chain

Finance.yahoo.com   DA: 17 PA: 19 MOZ Rank: 41

  • 38 rows · View the basic NTLA option chain and compare options of Intellia Therapeutics, Inc

72 ETFs With Intellia Therapeutics, Inc. (NTLA) Exposure

Etf.com   DA: 11 PA: 11 MOZ Rank: 28

  • The best-performing ETF in the past 12 months with NTLA as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%
  • ETF s with the most NTLA Exposure Ticker

Crispr Gene-Editing Breakthrough By Intellia (NTLA) Is A

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 74

  • For the first time, the gene-modifying technology was shown to work in the human body to treat disease, offering huge hope for further uses
  • Here’s what you need to know.

In Vivo Therapies

Intelliatx.com   DA: 18 PA: 19 MOZ Rank: 45

  • NTLA-2001, Intellia’s first investigational therapy, is being evaluated in a Phase 1 clinical trial as a treatment for people who have hereditary ATTR with polyneuropathy
  • Program: NTLA-2001 could be the first curative treatment for transthyretin (ATTR) amyloidosis
  • By applying the company’s in vivo.

Intellia Therapeutics, Inc. (NTLA) Stock Price Today

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 37

  • A high-level overview of Intellia Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Conference – NTLA

Ntla.info   DA: 13 PA: 12 MOZ Rank: 35

  • NTLA will return to an in-person event next April
  • The conference will be held at the beautiful Mystic Lake Center located in the Shakopee Mdewakanton Sioux Community in the Minneapolis-St
  • The theme for the conference is People, Purpose and Passion:

Intellia Therapeutics, Inc.

Zacks.com   DA: 13 PA: 21 MOZ Rank: 45

  • Zacks News for NTLA No Record found
  • Intellia Therapeutics is a leading genome editing company, focused on developing therapeutics utilizing a biological tool known as CRISPR-Cas9

How CRISPR Gene Editing Will Treat Disease: Intellia

Cnbc.com   DA: 12 PA: 50 MOZ Rank: 74

  • Why demand for CRISPR gene editing is increasing
  • Gene-editing technology CRISPR reached a major milestone this …

NTLA: Intellia Therapeutics Inc Stock Price Quote

Bloomberg.com   DA: 17 PA: 14 MOZ Rank: 44

Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Why Shares Of Intellia Therapeutics Are Jumping Today

Fool.com   DA: 12 PA: 50 MOZ Rank: 76

  • Wall Street may also be encouraged by the updated plans in the NTLA-2001 program
  • Management believes it will have data by the end of the year …

NTLA Foundation

Ntla.org   DA: 12 PA: 20 MOZ Rank: 47

  • The mission of the NTLA Foundation is to support owner-occupied homeowners with hardships
  • The purpose of the NTLA Foundation is to provide property preservation solutions to troubled homeowners and a resource for local governments and members of the National Tax Lien Association.

NTLA: Intellia Therapeutics Inc

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 40

Get Intellia Therapeutics Inc (NTLA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Intellia Therapeutics, Inc.

Thestreet.com   DA: 17 PA: 11 MOZ Rank: 45

Intellia And Regeneron Announce Landmark Clinical Data Showing Deep Reduction In Disease-Causing Protein After Single Infusion Of NTLA-2001, An …

NTLA Intellia Therapeutics Inc. Analyst Estimates

Marketwatch.com   DA: 19 PA: 38 MOZ Rank: 75

  • analyst estimates, including NTLA earnings per share estimates and analyst recommendations.

NTLA-Intellia Therapeutics, Inc.-基本資料-美股-MoneyDJ理財網

Money.moneydj.com   DA: 17 PA: 24 MOZ Rank: 60

藉由系統生物工具發展醫療學的基因編輯公司 Intellia Therapeutics, Inc.(NTLA.US)成立於2014年,原名「AZRN, Inc.」,2014年7月更為現名,總部位於麻州劍橋市,為一家基因編輯公司,專注於利用一個稱之為CRISPR/ Cas9系統的生物學工具發展療法。公司針對肝臟疾病發展之體內項目,包括:類澱粉沉積症 …

Intellia Therapeutics (NTLA) Plans Proposed Public

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 95

  • Intellia Therapeutics ( NTLA) announced yesterday, June 28, that the genome editing biotech company has commenced an underwritten public offering of $400 million worth of shares of Intellia Therapeutics common stock
  • Before market open today, NTLA shares dropped slightly to $130.50, which is a 2.20% decrease.

NTLA Intellia Therapeutics, Inc. Stock Quote

Finviz.com   DA: 10 PA: 11 MOZ Rank: 42

The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency.

Intellia Therapeutics Inc (NTLA) Quote

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 64

  • Learn about NTLA (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials
  • Start a 14-day free trial to Morningstar Premium to unlock our

Should You Buy NTLA Stock

Stockinvest.us   DA: 14 PA: 11 MOZ Rank: 48

  • The Intellia Therapeutics Inc stock price fell by -2.29% on the last day (Wednesday, 15th Sep 2021) from $153.97 to $150.44
  • and has now fallen 5 days in a row
  • During the day the stock fluctuated 5.10% from a day low at $147.77 to a day high of $155.30
  • The price has fallen in 6 of the last 10 days and is down by -6.29% for this period.

Intellia Therapeutics, Inc. Common Stock (NTLA) Stock

Nasdaq.com   DA: 14 PA: 28 MOZ Rank: 66

Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Home [nlta.govmu.org]

Nlta.govmu.org   DA: 14 PA: 14 MOZ Rank: 53

The National Land Transport Authority(Road Transport Division) As a service-oriented department is responsible for: • Registration and transfer of ownership of motor vehicles;

If You’re An Adventuresome Investor, Then Take A Chance On

Marketingsentinel.com   DA: 21 PA: 50 MOZ Rank: 97

  • In the last trading session, 1.74 million shares of the Intellia Therapeutics Inc
  • (NASDAQ:NTLA) were traded, and its beta was 2.13
  • Most recently the company’s share price was $157.29, and it changed around $3.44 or 2.24% from the last close, which brings the market valuation of the company to $1

Intellia (NTLA) Up On Positive Gene-Editing Drug Interim

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 91

  • Shares of Intellia Therapeutics, Inc
  • NTLA were up 50.21% on Monday after the company, along with its partner Regeneron Pharmaceuticals REGN, announced positive interim data from the ongoing phase

NTLA Price Target, Analyst Ratings And Predictions

Marketbeat.com   DA: 18 PA: 33 MOZ Rank: 79

  • According to the issued ratings of 17 analysts in the last year, the consensus rating for Intellia Therapeutics stock is Buy based on the current 3 hold ratings and 14 buy ratings for NTLA
  • The average twelve-month price target for Intellia Therapeutics is $143.38 with a high price target of $252.00 and a low price target of $52.00

NTLA Intellia Therapeutics Inc. Analyst Estimates

Wsj.com   DA: 11 PA: 41 MOZ Rank: 81

  • NTLA updated stock price target summary
  • Dow Jones, a News Corp company About WSJ
  • News Corp is a global, diversified media and information services company focused on creating and distributing

NTLA Stock Snapshot

Eresearch.fidelity.com   DA: 22 PA: 34 MOZ Rank: 86

The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency.

Intellia Therapeutics Stock Quote: NTLA Stock News, Quotes

Research.investors.com   DA: 22 PA: 50 MOZ Rank: 19

  • Zacks Equity Research 08/14/2021 02:00 AM ET
  • (NTLA) Reports Q2 Loss, Lags Revenue Estimates
  • (NTLA) delivered earnings and revenue surprises of -65.57% and -45.54%, respectively, for the quarter ended June 2021.

NTLA 13F Hedge Fund And Asset Management Owners

Whalewisdom.com   DA: 15 PA: 11 MOZ Rank: 58

  • ) HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
  • SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • 40 ERIE STREET CAMBRIDGE, MA 02139
  • Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system.

Intellia Therapeutics Inc NTLA

Money.usnews.com   DA: 16 PA: 48 MOZ Rank: 97

  • is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system
  • Its CRISPR/Cas9 system transforms

NTLA $NTLA Stock Charts, Analysis, Trend, Intellia

Stockconsultant.com   DA: 23 PA: 25 MOZ Rank: 82

  • 556.7k shares, -58.2% compared to typical daily volume over the past 6 months
  • Typical daily volume is 1.33mil shares over the past 6 months
  • RALLIES/PULLBACKS ** Current price area
  • Typical: 53.88 pts (35%) occurs 25% of the time
  • Extreme: 70.05 pts (45.5%) occurs 5% of the time.

NTLA Intellia Therapeutics Inc. Stock Overview (U.S

Barrons.com   DA: 15 PA: 24 MOZ Rank: 74

  • Complete Intellia Therapeutics Inc
  • View real-time NTLA stock price and news, along with industry-best analysis.

Intellia Therapeutics, Inc (NTLA) Q2 2021 Earnings Call

Fool.com   DA: 12 PA: 50 MOZ Rank: 98

NTLA-2002 leverages the same LNP delivery system as NTLA-2001, but targets the KLKB1 gene in the liver to permanently reduce plasma kallikrein protein and …

NTLA Stock Price And Chart — NASDAQ:NTLA — TradingView

Tradingview.com   DA: 19 PA: 21 MOZ Rank: 77

  • NTLA making an inverse head and shoulder pattern which really a beautiful setup
  • though I would most likely enter once it broke out the $85 price range with a confirmed volume new time high plays
  • price target for me would be around $150 to $200 with a bullish general market 0

What’s Happening With Intellia Therapeutics Stock

Forbes.com   DA: 14 PA: 50 MOZ Rank: 12

The stock price of Intellia Therapeutics (NASDAQ: NTLA), a biotechnology company developing treatments using a CRISPR gene-editing system, has …

Intellia Therapeutics, Inc. (NTLA) CEO John Leonard On Q2

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 11

NTLA-2002 leverages the same LNP delivery system as NTLA-2001, but targets the KLKB1 gene in the liver to permanently reduce plasma kallikrein protein and …

Intellia: FDA Accepts NTLA-5001 IND In Acute Myeloid Leukemia

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 10

  • Food and Drug Administration has accepted its investigational new drug application for NTLA-5001 in acute myeloid leukemia, a cancer of the blood and bone marrow
  • The Cambridge, Mass., clinical-stage genome-editing company said NTLA-5001 would be its first ex-vivo candidate

Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are

Investorplace.com   DA: 17 PA: 50 MOZ Rank: 9

  • Editas Medicine (NASDAQ: EDIT), Intellia Therapeutics (NASDAQ: NTLA) and CRISPR (NASDAQ: CRSP) are all up between 6% and 17% today
  • Source: Shutterstock These outsized moves come on a very green

Recently Analyzed Sites

Revo.com (4 hours ago)

Bobbyjonesband.com (2 day ago)

Huishoubao.com (3 hours ago)

M1file.com (3 day ago)

Renhomesantalya.com (10 day ago)

Trekksoft.com (12 min ago)

Tibbo.com (1 day ago)

Cycnow.com (6 seconds ago)

Tailspinbandsc.com (3 day ago)

Dungscanada.com (22 hours ago)

Jfsorange.org (4 day ago)

Marloweslu.com (2 day ago)